These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37737021)

  • 1. Efficacy and safety of laser-related therapy for melasma: A systematic review and network meta-analysis.
    Ma W; Gao Q; Liu J; Zhong X; Xu T; Wu Q; Cheng Z; Luo N; Hao P
    J Cosmet Dermatol; 2023 Nov; 22(11):2910-2924. PubMed ID: 37737021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Efficacy of Melasma Treatments: A Network Meta-Analysis of Randomized Controlled Trials.
    Liu Y; Wu S; Wu H; Liang X; Guo D; Zhuo F
    Front Med (Lausanne); 2021; 8():713554. PubMed ID: 34660626
    [No Abstract]   [Full Text] [Related]  

  • 3. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
    Debasmita B; Raj C; Ishan A; Ipsita D
    J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low-fluence 1064 nm Q-switched Nd: YAG laser for the treatment of melasma: A meta-analysis and systematic review.
    Chen J; Yu N; Peng L; Li H; Tang Y; Ou S; Zhu H
    J Cosmet Dermatol; 2022 Jul; 21(7):. PubMed ID: 35621242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
    Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
    Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel 532-nm Q-switched Nd: YAG laser for the treatment of melasma and rejuvenation: a prospective, randomized controlled comparison with 1,064-nm Q-switched Nd: YAG laser.
    Wu W; Su Q; Zhang Y; Du Y; Hu Y; Wang F
    Int J Dermatol; 2024 Sep; 63(9):1242-1251. PubMed ID: 38411341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
    Alsaad SM; Ross EV; Mishra V; Miller L
    Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study.
    Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S
    Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients.
    Yue B; Yang Q; Xu J; Lu Z
    Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
    Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
    J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Topical Silymarin Versus Low Fluence 1064-nm Q Switched Nd:YAG Laser in the Treatment of Melasma: A Comparative Randomized Trial.
    Ibrahim SMA; Farag AS; Ali MS; El-Gendy WMAF
    Lasers Surg Med; 2021 Dec; 53(10):1341-1347. PubMed ID: 34101206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Toning Method with the Combination of Picosecond and Microsecond Nd:YAG in Refractory Melasma Unresponsive to Picosecond Alone.
    Hai L; Phuong B; Ha L; Lam V; Van B; Al-Niaimi F
    J Cutan Aesthet Surg; 2021; 14(1):101-106. PubMed ID: 34084016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy.
    Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
    J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Low Power Fractional CO
    Esmat S; Z Elramly A; Shahin D; Hilal RF
    Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the combination of Q-switched Nd:YAG laser and microneedling for melasma.
    Karadağ Köse Ö; Borlu M
    J Cosmet Dermatol; 2021 Mar; 20(3):769-775. PubMed ID: 32696614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination treatment of low-fluence 1,064-nm Q-switched Nd: YAG laser with novel intense pulse light in Korean melasma patients: a prospective, randomized, controlled trial.
    Yun WJ; Moon HR; Lee MW; Choi JH; Chang SE
    Dermatol Surg; 2014 Aug; 40(8):842-50. PubMed ID: 25022705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness and safety of topical methimazole 5% monotherapy versus combination of Q-Switched Nd: YAG Laser and topical methimazole 5% in patients with refractory melasma.
    Beyzaee AM; Goldust M; Rokni GR; Patil A; Mostaghiman R; Golpour M
    J Cosmet Dermatol; 2023 Jun; 22(6):1774-1779. PubMed ID: 36847668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation.
    Agamia N; Apalla Z; Salem W; Abdallah W
    J Dermatolog Treat; 2021 Nov; 32(7):819-826. PubMed ID: 31908179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review.
    Lee YS; Lee YJ; Lee JM; Han TY; Lee JH; Choi JE
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.